Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigations of; La Quinta Holdings Inc., DS Healthcare Group, Inc., LPL Financial Holdings Inc., Amaya Inc. and Carbylan Therapeutics

Zwei Frauen beim Shopping (Symbolbild). © filadendron / E+ / Getty Images

PR Newswire

SAN DIEGO, March 25, 2016

SAN DIEGO, March 25, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential claims against La Quinta Holdings Inc., DS Healthcare Group, Inc., LPL Financial Holdings Inc., Amaya Inc. and Carbylan Therapeutics, Inc., as detailed below:

La Quinta Holdings Inc.

Johnson & Weaver, LLP is investigating whether certain public filings made by La Quinta Holdings Inc. (NYSE: LQ) in connection with the Company's initial public offering (IPO) and the subsequent secondary offerings complied with federal securities laws. Specifically, Johnson & Weaver's investigation seeks to determine whether certain statements regarding La Quinta's business metrics and financial prospects were not as strong as represented in the Registration Statement.

If you have information that could assist in this investigation, or if you are a La Quinta shareholder who suffered a loss on that investment and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

DS Healthcare Group, Inc.

Johnson & Weaver, LLP has commenced an investigation concerning whether DS Healthcare Group, Inc. (NASDAQ: DSKX) violated federal securities laws.

On March 23, 2016, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity transactions and should no longer be relied upon. DS Healthcare disclosed that it will restate the relevant financial statements as soon as possible. DS Healthcare also announced that the Audit Committee and independent counsel had started an investigation in connection with DS Healthcare's President, Daniel Khesin, for alleged fraudulent revenue recognition and equity transaction errors.

ARIVA.DE Börsen-Geflüster

Kurse

DS HEALTHCARE GROUP

0,00%

KalVista Pharmaceuticals

10,67 $

-4,82%

If you are a DS Healthcare shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

LPL Financial Holdings Inc.

Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by LPL Financial Holdings Inc. (NASDAQ: LPLA) and certain of its officers. A class action lawsuit against the Company has been filed on behalf of shareholders who purchased LPL between December 8, 2015 and February 11, 2016 (the "Class Period").

If you have held shares continuously prior to December 8, 2015, you may have standing to hold LPL Financial Holdings harmless from the damage the officers and directors caused by making them personally responsible. You may also be able to assist in reforming the Company's corporate governance to prevent future wrongdoing.

If you are an LPL shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If you email, please include your phone number.

Amaya Inc.

Johnson & Weaver, LLP is investigating whether certain officers and directors of Amaya Inc., (NASDAQ: AYA) violated state or federal laws. On March 23, 2016, Amaya disclosed that Quebec's securities regulator has filed insider trading charges against Amaya's Chairman and Chief Executive Officer, David Baazov. The charges are for aiding with trades while in possession of privileged information and influencing or attempting to influence the market price of Amaya securities. On this news, shares of Amaya fell sharply during intraday trading on March 23, 2016.

If you have information that could assist in this investigation (especially as a former employee), or if you are a AMAYA shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

Carbylan Therapeutics, Inc.

Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Carbylan Therapeutics, Inc. (NASDAQ: CBYL) and certain of its officers in connection with the Company's initial public offering (IPO). Specifically, Johnson & Weaver's investigation seeks to determine whether certain statements regarding the Company's business metrics and financial prospects were not as strong as represented in the Registration Statement.

If you have information that could assist in this investigation, or if you are a Carbylan shareholder who suffered a loss on that investment and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:

Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

Logo - http://photos.prnewswire.com/prnh/20160211/332409LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-rights-law-firm-johnson--weaver-llp-initiates-investigations-of-la-quinta-holdings-inc-ds-healthcare-group-inc-lpl-financial-holdings-inc-amaya-inc-and-carbylan-therapeutics-inc-encourages-investors-to-co-300241597.html

SOURCE Johnson & Weaver, LLP

Mehr Nachrichten zur DS HEALTHCARE GROUP Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.